Medical-themed funds are surging, and there is a high level of focus on the innovative drug sector.

"After nearly five years, the pharmaceutical theme fund has finally started to make money." In recent days, the pharmaceutical market has continued to rebound, which has caught the eye of many investors. With the pharmaceutical sector, especially the innovative drug segment, gradually receiving market attention, many public fund companies have begun to promote pharmaceutical theme funds, and many pharmaceutical fund managers have been appearing frequently. In the eyes of public fund professionals, the resurgence of the pharmaceutical market is not simply driven by short-term market sentiment. After nearly five years of adjustment, several negative factors that previously constrained the performance of the pharmaceutical sector are gradually fading away. The pharmaceutical sector, especially in the innovative drug field, has seen many new changes. Many fund managers believe in the investment opportunities in the pharmaceutical sector, especially in the innovative drug segment, in the future.